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INTRODUCTION
Growth promoting implants have been used extensively in beef production for over 30
years. Significant changes in implants and implanting strategies have occurred. Prior to 1987,
available implants were estrogenic agents which metabolically enhanced nutrient use to enhance
growth. These products improved feed efficiency 5-10 percent and daily gains from 5-15 percent.
In 1987, the androgenic (tissue building) agent, trenbolone acetate, was approved for use in
growth promoting implants. This compound had an additive effect with existing estrogenic
implants. The androgenic implant enhanced muscle growth and added an additional 2-3 percent
to the feed efficiency and 3-5 percent to the daily gains. The return on implant investment varies,
but only in rare situations do implants return less than $5 per $1 spent. Implants are available for
all cattle except calves less than 45 days old and most breeding cattle. Proper scheduling and use
of implants should return in excess of $10 per $1 spent.
Today, implants have become almost designer products with varied doses and
combinations of estrogenic and/or androgenic agents. While implants tend to be most effective in
feed yards, implanting strategies have been effectively applied to other beef
production situations. The growth promoting implants approved for use in the United States are
extremely safe. They are safe not only for the cattle, but for producers who use the products and
for the consumers who consume the beef produced from implanted cattle. There is no
withdrawal time for any of the approved implants available in the United States.

MECHANISM OF ACTION
Cattle must have adequate nutrition before implants can positively influence feed
efficiency and gain. The greatest response to implants tends to be observed in older cattle, such
as yearlings, near peak periods of lean tissue deposition. Typically these would be yearling cattle
consuming high levels of high energy feed.
Estrogenic implants increase the circulating levels of somatotropin (ST) and insulin-like
growth factor-1 (IGF-1). Both of these substances are produced by the animal and have a marked
effect on how nutrients are used by the animal to produce muscle, bone, and fat. The approved
androgenic agent, trenbolone acetate (TBA), does not seem to stimulate the production of ST, but
1

does significantly increase the circulating levels of IGF-1 and decreases the normal loss of
muscle tissue in sedentary animals. The implant response is associated with nutrients available
and the level of implant growth promotant circulating in the animal.
When growth promoting implants are first placed in the animal, there is a rapid release of
hormone from the implant. The level of growth promotant being released from the implant will
begin to fall after a few days, but will remain above an effective growth stimulating level
"threshold" for a varying length of time depending on the pharmaceutical design of the implant
and the quality of technique used when administering the implant placement. Reimplanting, the
administration of an additional implant, is usually scheduled to coincide with the declining level
of circulating implant growth promotant, but always above threshold. The optimum reimplant
time is referred to as the reimplant window. For maximum benefit, it is important to maintain the
level of implant growth promotant above threshold throughout the ownership of the stocker or
feeder animal. The length of time an implant releases growth promotant varies from
approximately 75 days for Ralgro® to the manufacturer’s estimated 200 days for Compudose®.
The improvements in rates of gain appear to follow the declining level of growth promotant
released from an implant. Therefore, the highest rates of gain can be expected during the first part
of the release period.
Because implant growth promotants interact with the production of hormones by the
animal, they have not been recommended or approved for use in breeding cattle or calves less
than 45 days of age as hormone production in these animals has not yet started.

IMPLANT PERFORMANCE
The estrogenic implants approved for use in suckling calves will improve weaning
weights 3-5 percent. Similar performance improvements can be seen in pastured stocker cattle
when the base gain is above 1.5 pounds per day.
Previously implanted cattle are of concern to cattle buyers who take advantage of
compensatory gain potential of cattle. Producers who do not implant suckling calves or stocker
cattle should receive a premium equivalent to the loss of production they would have achieved
had they implanted.
In feeder cattle, estrogenic growth promoting implants improve feed efficiency and gain
5-15 percent. Implants which include TBA can provide an additional 3-5 percent improvement in
feed efficiency and daily gain. A properly designed reimplant program can sustain implant
associated improved performance beyond the payout that would be expected for a single implant.
For estrogenic implants used in yearling cattle fed typical feedlot rations, at least a $5
return above the cost of the implant can be expected for each $1 price of a bushel of corn.
Adding TBA to an estrogen implant system will return an additional $2 above the cost of the
implant for each $1 price of a bushel of corn. For example, if corn costs $3 per bushel, an
estrogenic implant would return approximately $15.
Limited data suggest cull cows respond to implants at or above the level of younger
feeder animals, especially to TBA. Most cull cows are not fed long enough to consider a
reimplanting program.

IMPLANT USE
Regulations governing the use of implants are set by the U.S. Food and Drug
Administration (FDA). Always read and follow the manufacturer’s directions before implanting.
The only approved location for implant administration is the middle third of the back side
of the ear. All implants must be located within this area (Figure 1). This location has been
chosen because the ear is removed and discarded at time of slaughter, reducing any food supply
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risk. If part of the ear has been lost
because of frost bite or injury, the
implant should be placed in the last
third of the ear. This should place
the implant outside the cartilage
ring at the base of the ear. Implants
should never be placed in locations
other than the ear.
Improper implanting
technique and resulting defects are
a serious economic concern because
of associated performance loss.
Defects of concern include
abscesses, expelled implants,
Figure 1.
cartilage embedment, crushed
pellets, missing pellets, and bunched pellets. Identification of a problem is not difficult but
identifying the cause may be more of a problem. Generally abscesses will be enlarged and will
feel doughy. If the abscess ruptures, the implant will be expelled leaving a very small ring of scar
tissue. Some implant sites will accumulate fluid that is not associated with an infection and do
not seem to be associated with implanting technique. Cartilage embedment should be suspected
when the implant feels firmly attached to the deeper tissues of the ear or when you cannot feel
the roughened edge of the implant. Published data (Hollis, 1989; Rains and Nash, 1990) outline
associated economic loss from these defects. Unpublished data from the University of Nebraska
Great Plains Veterinary Educational Center during the summer of 1996 suggest abnormal
implants are associated with 0.17 pound reduction in carcass gain in cattle fed 150 days¹.
Common sense suggests better performance could be expected in cattle free of implant defects.

RECOMMENDATIONS OF CORRECT SANITATION PROCEDURES
WHEN IMPLANTING
The major sanitation problem to overcome is the removal of fecal material
(manure) from the implant area, containing bacteria, by simple cost effective procedures.
These procedures physically remove the manure, dirt and bacteria, and also apply a
disinfectant solution to the implant injection site surface of the ear. Only with a bacteria
free implant injection site and a clean, disinfected implant needle can consistent abscess
free implanting results be obtained.
Coliform bacteria are normal inhabitants of an animal’s digestive tract, and during
handling and processing can be spread to the hair and skin surfaces of cattle. As cattle are
gathered and driven to the processing area, and are processed through cattle facilities,
fecal material can be deposited on various parts of the body simply by close contact. This
is unavoidable but can be reduced by less crowding and limiting the time spent in a
confined area. Fecal material becomes a problem when injections are made through
contaminated skin and hair. Implants, other pharmaceuticals and vaccines can be made
partially or totally ineffective when bacteria are carried into the injection site by the
needle; logically, the larger the needle gauge the more debris that can be carried into the
injection site. The animal’s body provides the perfect environment for opportunistic
microorganisms to grow and multiply. As a consequence of the microbial growth and
subsequent infection, abscesses are formed and can result in the possible reduced efficacy
of the animal health product administered.
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As expected, growth implant efficacy and return on investment decreases as
abscess severity increases. Cattle having complete abscesses where all implant pellets are
expelled from the injection site have similar performance to cattle not given a growth
implant. Typically, with complete abscesses the implant pellets are expelled within three
to five days following implanting. Perhaps the largest unknown is the decrease of growth
implant efficacy that occurs when slight to moderate abscesses develop which limit drug
absorption by tissues surrounding the implant.
Kansas State University research (Spire et al., 1999) reported average daily gains
were decreased 8.9% (3.18 versus 2.92 pounds) and feed efficiency decreased 8.5% (5.62
versus 6.14 pounds of feed per pound of gain) by abscessed growth implants. It is
imperative employees receive instruction on proper implant technique and sanitation
procedures. Some cattle operations continue to have a great deal of variation in proper
implanting rates because they fail to recognize that dirty ears can cause abscesses, and are
unwilling to implement cleaning procedures.
A number of years ago a method called “scrape, brush and disinfect” was
introduced to raise the awareness of ear sanitation prior to implanting by cattle processing
personnel. In this method an initial assessment of ear surface cleanliness is made. If the
ear is clean and dry, the implant is administered. If the ear is dirty (wet or dry), a dulled
steak knife is used to scrape foreign material from the ear prior to brushing the ear with
disinfectant solution and implant administration. If the ear is wet, but contains no foreign
material, it is brushed and disinfectant solution and the implant given. The type of brush
used to clean and disinfect the ears is two-sided with brass bristles on one side and nylon
bristles on the other. When the brush is not in use, it is placed in a small bucket of
disinfectant solution.
Choice of disinfectant is extremely important for effective control against the
major microorganisms that can cause growth implant abscesses. One of the most effective
and safest disinfectants is Nolvasan (chlorhexidine acetate) and is licensed by the EPA. It
has a rapid bactericidal antiseptic action with sustained residual activity for as long as two
days. It also retains anti-microbial activity in the presence of organic matter. (Taken from
Fort Dodge Animal Health Technical Bulletin FDP 310 8/99.)
Some feedyards coat the cleaned implanting needle with an approved, non-irritating
antibiotic between animals as an additional safeguard to help prevent implant site infections.
Visit with your veterinarian about the selection, dilution, and use of a disinfectant.
Developing a light touch and slightly rotating the needle when implanting is the best
defense against cartilage embedment. A properly placed implant will be slightly movable.
Missing or bunching of implant pellets can be avoided by carefully restraining the animal
and slowly withdrawing the implant needle as the implant is being administered. Implant guns
and needles are available from the companies that manufacture growth promoting implants. All
implants can be effectively administered with the implant gun designed for the associated
implant. It is important to visually inspect and physically palpate the implant site after the
implant is administered to ensure the implant is properly placed and all the pellets in the pelleted
implants are properly aligned. As part of the inspection, the implant needle opening should be
closed by pressing down on the hole. Most of the problems with implant guns can be avoided by
closely following the manufacturer’s directions.
Routine inspection of implant and vaccine sites should be done every time animals are
handled through a chute and at periodic quality audits performed at packing houses. A practical
and consistent inspection can be accomplished on each animal that enters the hospital pen.
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IMPLANTS COMMERCIALLY AVAILABLE
Currently available implants vary in type and concentration of active anabolic compound
(Table 1).
Table 1. Currently available implants (as of 4/00), active ingredients and
concentrations.
Trade Name
Ralgro
Ralgro Magnum
Synovex-C
Component E-C
Synovex-S
Implus-S
Component E-S
Synovex-H
Implus-H
Component E-H
Compudose
Encore
Finaplix-S
Component T-S
Finaplix-H
Component T-H
Revalor-G
Revalor-S
Component TE-S
Revalor-H
Synovex-Plus
Revalor 200
a

Active Ingredient

Concentration (mg)

zeranol
zeranol
estradiol benzoate
progesterone
(Synovex-C “look-alike”)
estradiol benzoate
progesterone
(Synovex-S “look-alike”)
(Synovex-S “look-alike”)
estradiol benzoate
testosterone propionate
(Synovex-H “look-alike”)
(Synovex-H “look-alike”)
estradiol
estradiol
TBAa
(Finaplix-S “look-alike”)
TBA
(Finaplix-H “look-alike”)
TBA
estradiol
TBA
estradiol
(Revalor-S “look-alike”)
TBA
estradiol
TBA
estradiol benzoate
(Synovex Plus “look-alike”)

36
72
10
100
20
200

20
200

25.7
43.9
140
200
40
8
120
24
140
14
200
28

TBA = trenbolone acetate

Table 2. Implant marketers (4/00).
Trade Name

Marketer

Synovex-C, Synovex-S, Synovex-H, Synovex-Plus
Finaplix-S, Finaplix-H, Revalor-S, Revalor-H, Revalor 200
Revalor-G
Implus-S, Implus-H
Ralgro, Ralgro Magnum
Compudose, Encore, Component E-S, E-H, T-S, T-H, TE-S
Component-TEG

Ft. Dodge
Intervet (Hoechst Roussel)
Intervet
Pharmacia-Upjohn
Schering-Plough
Vetlife

Vetlife

All of the implants, except Ralgro and Ralgro Magnum, contain either estradiol (E2), trenbolone acetate (TBA) or the
combination of E2 and TBA.
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Tables 3 through 5 list implants approved for use in suckling calves, stocker and feedlot
cattle respectively. Estimates of the effective life for each implant are based on conclusions
drawn by various scientists from published field trials as well as company claims based on
explant and blood assay research. As you can see, determination of the effective life of an
implant is an imprecise process at best. That should not be a surprise given the numerous factors
involved (e.g. implanting technique). Estimates are useful for recommending an optimum time
for reimplanting. However, it is not appropriate to use them to compare implants. Amount of
additional weight gained is the bottom line, not how long it took an implant to produce the added
weight. Effective life is not the only factor affecting how much additional weight is gained.

Table 3. Implants currently (4/00) available for use in suckling calves*.
Trade name

Approved for:

Estimates of effective life, days

Ralgro
Synovex-C
Component E-C
Implus-C
Compudose
Encore

steers/heifers
steers/heifers
(Synovex-C “look-alike”)
(Synovex-C “look-alike”)
steers
steers

100-120
100-120

200
400

*

Do not implant implant heifers intended for breeding.

Table 4. Implants currently (4/00) available for use in stocker cattle.
Trade name

Approved for:

Estimates of effective life, days

Ralgro
Synovex-S
Implus-S
Component E-S
Synovex-H
Implus-H
Component E-H
Compudose
Encore
Revalor-G
Component-TEG

steers/heifers
steers
(Synovex-S “look-alike”)
(Synovex-S “look-alike”)
heifers
(Synovex-H “look-alike”)
(Synovex-H “look-alike”)
steers
steers
steers/heifers
(Revalor-G “look-alike”)

60-120
80-120
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80-120

200
400
???

???

Table 5. Implants currently (4/00) available for use in feedlot cattle.
Trade name

Approved for:

Estimates of effective life, days

Ralgro
Ralgro Magnum
Synovex-C
Synovex-S
Impuls-S
Component E-S
Synovex-H
Implus-H
Component E-H
Compudose
Encore
Component T-S
Finaplix-H
Component T-H
Revalor-S
Component TE-S
Revalor-H
Synovex-Plus
Revalor 200

steers/heifers
steers
steers
steers
(Synovex-S “look-alike”)
(Synovex-S “look-alike”)
heifers
(Synovex-H “look-alike”)
(Synovex-H “look-alike”)
steers/heifers
steers/heifers
(Finaplix-S “look-alike”)
heifers
(Finaplix-H “look-alike”)
steers
(Revalor-S “look-alike”)
heifers
steers/heifers
steers/heifers

60-80
80-120
60-80
80-120

80-120

200
400
80-90
100-120
100-120
90-110
90-110

OTHER CONSIDERATIONS
Implanting heifers intended to enter the breeding herd is controversial. The mixed results
from research trials suggest detailed management considerations must be adhered to before
considering an implant program for replacement heifers. Implant once and not younger than the
age directed. Highlights of these considerations include selecting an implant approved for use in
replacement heifers, providing adequate nutrition for growth, and leaving adequate time between
implanting and breeding.
Implanting replacement breeding bull calves is not approved or recommended.

IMPLANTING STRATEGIES
It is important to implant cattle as soon as practical. In suckling calves, the traditional
branding time provides an excellent opportunity to implant and vaccinate most of the calves in
the herd. Prior to bull turn out, the preferred procedures include vaccination with subcutaneously
administered modified live four way viral and clostridial vaccines, and implanting calves older
than 45 days old with a product designed for suckling calves. It is important not to implant
replacement heifers intended to be kept for breeding purposes unless strict adherence to
manufacturer’s directions are followed and never implant bull calves.
At weaning, calves not intended for breeding should be implanted again with a more
aggressive implant. The feeder implant can be either an estrogenic implant or a combination
estrogenic-trenbolone implant. It appears to be important to finish the feeding period with the
most potent implant selected in the implanting program. Therefore, if a combination
estrogenic-trenbolone implant is selected as the first implant, it should be used again in
subsequent implantings. If an estrogenic implant without trenbolone is selected as the first
implant, a similar product or an estrogenic-trenbolone implant can be selected for subsequent
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implanting.
Reimplant schedules should be developed to reflect the targeted finish date, the historic
grade price spreads, the genetic potential of the cattle, and the feeding program available. From
the projected finish date, reimplanting should be scheduled by back calculating the payout days
of the last implant intended for use.
For example, if 550-pound medium to large frame weaned steer calves enter the feedyard
the first of October, an estrogenic product such as Magnum®, Synovex-S®, or Implus-S® can be
selected as the initial implant. If the cattle are projected to gain 3 pounds per day and be marketed
at 1,100 pounds, the estimated sale date would be the first two weeks of April. Back calculating
the 120-day payout of a combination estrogenic-trenbolone implant from the middle of April,
reimplanting would be scheduled for the middle to the end of December.
Maintaining implanting schedules can be very difficult, but tremendous performance
advantages can be achieved if properly managed. If you have any questions, seek the advice of a
qualified feedlot nutritionist or veterinarian.

Figure 2. Possible Implant Programs and Use Relative to Days from the Packer.

RATION CONSIDERATIONS
Although no special ration considerations are needed for maximal implant performance, it
is important to feed a balanced high quality ration. All approved feed additives used in an
approved manner are appropriate to consider in a feeding program for implanted cattle.
Performance improvements associated with approved feed medications are additive to the
expected performance improvements from implants.

SIDE EFFECTS
Heavy carcass weight can be a problem when feeding large frame exotic long yearlings.
Typically, implanted cattle will be heavier when finished, if fed for the same amount of time, and
with the same quality grade as non-implanted cattle.
Poor yield grades have been reported in heifers implanted with combination
estrogenic-trenbolone implants and concurrently fed the feed additive melengesterol acetate
(MGA). These observations were made in studies designed to evaluate the benefits of a
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combination implant. It is likely the heifers were fed too long. It is important in any feedlot
management program to evaluate cattle near their target finishing date, and market the cattle as
soon as they reach the most economical degree of finish.
Poor quality grades can be a problem if implanting schedules are not properly designed to
match the age, weight, genetics, and nutritional management of the cattle. It is always important
to consider the historic quality grade price spreads at the targeted finishing date. Implanting does
have an effect on marbling and grading, depending on the implant strategy employed, and this
can affect quality grade.
An increase in the buller rate has been reported with the use of some implants. Crushing
implants has also been blamed on the increased buller rate in some groups of implanted animals.
With the modern implanting tools available today, this problem seems unlikely. The effects of
climatic changes, ambient temperature, animal handling, commingling, feed stuffs containing
fungal or plant estrogens, and implant technique seem more likely to play a role in these
observations.
Vaginal and rectal prolapses have been reported as an implant side effect. If hormones are
involved in these occurrences, it is possible additional estrogenic compounds from the feed are
also involved. These compounds could come from feed molds or from some classes of feeds such
as legumes containing phytoestrogens. Other suspected causes include improper implanting
technique or improper implant scheduling.
High tailheads, sunken loins, udder development, and heavy hide weights have also been
reported. These problems are generally rare or have minor economic significance when compared
to the performance benefit realized from the use of implants.

CONCLUSIONS
Using growth promoting implants is one of the most cost effective methods of enhancing
cattle gain and efficiency of gain. Implants enhance protein deposition while diminishing fat
accretion. Properly designed implant programs should take into account animal age, sex, weight,
breed and market objectives. Meat and animal products from cattle implanted with growth
promotants are as safe and acceptable as comparable products derived from nonimplanted cattle.
For those producers who choose not to implant, there are niche markets that may be developed,
providing beef products to individuals who desire this type of beef.
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